XSAT:CSMED (Denmark)
Â
Unit (5 Ord Shares & 2 Wrts Ser 1)
kr
3.23
(-7.71%)
Jun 3
Business Description
CS Medica AS
ISIN : DK0061668225
Share Class Description:
XSAT:CSMED: Unit (5 Ord Shares & 2 Wrts Ser 1)Compare
Compare
Traded in other countries / regions
8G8.GermanyCSMED.Sweden IPO Date
2021-09-14Description
CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.22 | |||||
| Debt-to-Equity | 1.69 | |||||
| Debt-to-EBITDA | -0.72 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.06 | |||||
| Beneish M-Score | -6.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -23.5 | |||||
| 3-Year EPS without NRI Growth Rate | -518 | |||||
| 3-Year FCF Growth Rate | -90.4 | |||||
| 3-Year Book Growth Rate | 372.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.1 | |||||
| 9-Day RSI | 34.17 | |||||
| 14-Day RSI | 38.05 | |||||
| 6-1 Month Momentum % | 54.74 | |||||
| 12-1 Month Momentum % | -29.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.42 | |||||
| Quick Ratio | 0.13 | |||||
| Days Inventory | 662.95 | |||||
| Days Sales Outstanding | 487.65 | |||||
| Days Payable | 1050.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.2 | |||||
| Shareholder Yield % | -10.93 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.08 | |||||
| Operating Margin % | -645.97 | |||||
| Net Margin % | -550.37 | |||||
| FCF Margin % | -268.05 | |||||
| ROE % | -104.35 | |||||
| ROA % | -55.82 | |||||
| ROIC % | -58.74 | |||||
| ROC (Joel Greenblatt) % | -436.9 | |||||
| ROCE % | -84.7 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 14.82 | |||||
| PB Ratio | 5.95 | |||||
| EV-to-EBIT | -2.87 | |||||
| EV-to-EBITDA | -3.25 | |||||
| EV-to-Revenue | 19.04 | |||||
| EV-to-FCF | -7.57 | |||||
| Earnings Yield (Greenblatt) % | -34.81 | |||||
| FCF Yield % | -18.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CS Medica AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 2.682 | ||
| EPS (TTM) (kr) | -1.197 | ||
| Beta | 0 | ||
| Volatility % | 108.77 | ||
| 14-Day RSI | 38.05 | ||
| 14-Day ATR (kr) | 0.549052 | ||
| 20-Day SMA (kr) | 3.888 | ||
| 12-1 Month Momentum % | -29.1 | ||
| 52-Week Range (kr) | 2.01 - 6.54 | ||
| Shares Outstanding (Mil) | 12.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CS Medica AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CS Medica AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
CS Medica AS Frequently Asked Questions
What is CS Medica AS(XSAT:CSMED)'s stock price today?
The current price of XSAT:CSMED is kr3.23. The 52 week high of XSAT:CSMED is kr6.54 and 52 week low is kr2.01.
When is next earnings date of CS Medica AS(XSAT:CSMED)?
The next earnings date of CS Medica AS(XSAT:CSMED) is 2024-08-16.
Does CS Medica AS(XSAT:CSMED) pay dividends? If so, how much?
CS Medica AS(XSAT:CSMED) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers